Başağrısı: Migren ve İlişkili Sendromlar

Yazarlar

Özet

Migren, dünya genelinde engelliliğin sık nedenlerinden biri olup akut ataklar hastaların acil servis başvurularının yaygın bir nedenidir. Migrenli hastaların tedavisinde, sinir blokajları ve yeni farmakolojik ilaç grupları için ortaya çıkan kanıtlarla birlikte son zamanlarda önemli ilerlemeler kaydedilmiştir. Bu bölüm, migrenin akut komplikasyonlarının tanısı, tedavisi ve yönetimi ile acil serviste migrene yönelik tedavilerin kullanımı hakkında bilgi içermektedir. Migreni önleyici ilaçların rolünü vurgulayarak ve acil servis hekimlerinin bu ilaçları uygun hastalara reçete edebilmesi için bakış açısı sunmaktadır. Ayrıca, migren tedavisinde sinir blokajları için kanıtları değerlendirerek acil serviste kullanımları hakkında bilgi verir. 

Referanslar

Amiri P, Kazeminasab S, Nejadghaderi SA, et al. Migraine: A Review on Its History, Global Epidemiology, Risk Factors, and Comorbidities. Frontiers in Neurology. 2022;12:800605. Published 2022 Feb 23. doi:10.3389/fneur.2021.800605

Pescador Ruschel MA, De Jesus O. Migraine Headache. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan- . Available from: https://www.ncbi.nlm.nih.gov/books/NBK560787/ [Accessed: 19th August 2024].

Ashina M, Katsarava Z, Do TP, et al. Migraine: epidemiology and systems of care. Lancet. 2021; 397:1485. doi: 10.1016/S0140-6736(20)32160-7.

Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007; 68:343. doi: 10.1212/01.wnl.0000252808.97649.21.

Brennan KC, Bates EA, Shapiro RE, et al. Casein kinase iδ mutations in familial migraine and advanced sleep phase. Science Translational Medicine. 2013; 5:183ra56, 1-11. doi: 10.1126/scitranslmed.3005784.

Lafrenière RG, Cader MZ, Poulin JF, et al. A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nature Medicine. 2010; 16:1157. doi: 10.1038/nm.2216.

Ashina M. Migraine. New England Journal of Medicine. 2020; 383:1866. doi: 10.1056/NEJMra1915327.

Charles A. Vasodilation out of the picture as a cause of migraine headache. Lancet Neurology. 2013; 12:419. doi: 10.1016/S1474-4422(13)70051-6.

Bolay H, Reuter U, Dunn AK, et al. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nature Medicine. 2002; 8:136. doi: 10.1038/nm0202-136.

Bartsch T, Goadsby PJ. Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input. Brain. 2002; 125:1496. doi: 10.1093/brain/awf166.

Bartsch T, Goadsby PJ. Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater. Brain. 2003; 126:1801. doi: 10.1093/brain/awg190.

Noseda R, Burstein R. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain. Pain. 2013;154 Suppl 1:10.1016/j.pain.2013.07.021. doi:10.1016/j.pain.2013.07.021

Ashina M, Hansen JM, Do TP, Melo-Carrillo A, Burstein R, Moskowitz MA. Migraine and the trigeminovascular system-40 years and counting. Lancet Neurology. 2019;18(8):795-804. doi:10.1016/S1474-4422(19)30185-1

Puledda F, Silva EM, Suwanlaong K, Goadsby PJ. Migraine: from pathophysiology to treatment. Journal of Neurology. 2023;270(7):3654-3666. doi:10.1007/s00415-023-11706-1

Sarchielli P, Alberti A, Floridi A, Gallai V. Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients. Neurology. 2001; 57:132. doi: 10.1212/wnl.57.1.132.

Burstein R. Deconstructing migraine headache into peripheral and central sensitization. Pain. 2001; 89:107. doi: 10.1016/s0304-3959(00)00478-4.

Bahra A, Matharu MS, Buchel C, et al. Brainstem activation specific to migraine headache. Lancet. 2001; 357:101. doi: 10.1016/s0140-6736(00)04250-1.

Welch KM, Nagesh V, Aurora SK, Gelman N. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache. 2001; 41:629. doi: 10.1046/j.1526-4610.2001.041007629.x.

Deen M, Christensen CE, Hougaard A, et al. Serotonergic mechanisms in the migraine brain - a systematic review. Cephalalgia. 2017; 37:251. doi: 10.1177/0333102416640501.

Hamel E. Serotonin and migraine: biology and clinical implications. Cephalalgia. 2007; 27:1293. doi: 10.1111/j.1468-2982.2007.01476.x.

Panconesi A. Serotonin and migraine: a reconsideration of the central theory. Journal of Headache and Pain. 2008; 9:267. doi: 10.1007/s10194-008-0058-2.

Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Annals of Neurology. 1993; 33:48. doi: 10.1002/ana.410330109.

Lassen LH, Haderslev PA, Jacobsen VB, et al. CGRP may play a causative role in migraine. Cephalalgia. 2002; 22:54 doi: 10.1046/j.1468-2982.2002.00310.x.

Benarroch EE. CGRP: sensory neuropeptide with multiple neurologic implications. Neurology. 2011; 77:281. doi: 10.1212/WNL.0b013e31822550e2.

Lamy C, Giannesini C, Zuber M, et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atrial Septal Aneurysm. Stroke. 2002; 33:706. doi: 10.1161/hs0302.104543.

Pierangeli G, Cevoli S, Zanigni S, et al. The role of cardiac diseases in the comorbidity between migraine and stroke. Neurological Sciences. 2004; 25 Suppl 3:S129. doi: 10.1007/s10072-004-0270-z.

Martin VT, Behbehani MM. Toward a rational understanding of migraine trigger factors. The Medical Clinics of North America. 2001; 85:911. doi: 10.1016/s0025-7125(05)70351-5.

Kelman L. The triggers or precipitants of the acute migraine attack. Cephalalgia. 2007; 27:394. doi: 10.1111/j.1468-2982.2007.01303.x.

Yoo A, Vgontzas A, Chung J, et al. The association between multidimensional sleep health and migraine burden among patients with episodic migraine. Journal of clinical sleep medicine. 2023; 19:309. doi: 10.5664/jcsm.10320.

Laurell K, Artto V, Bendtsen L, et al. Premonitory symptoms in migraine: A cross-sectional study in 2714 persons. Cephalalgia. 2016; 36:951. doi: 10.1177/0333102415620251.

Hansen JM, Lipton RB, Dodick DW, et al. Migraine headache is present in the aura phase: a prospective study. Neurology. 2012; 79:2044. doi: 10.1212/WNL.0b013e3182749eed.

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018; 38:1. doi: 10.1177/0333102417738202.

Thomsen AV, Ashina H, Al-Khazali HM, et al. Clinical features of migraine with aura: a REFORM study. Journal of Headache and Pain. 2024; 25:22. doi: 10.1186/s10194-024-01718-1.

Cutrer FM, Huerter K. Migraine aura. Neurologist. 2007; 13:118. doi: 10.1097/01.nrl.0000252943.82792.38.

Giffin NJ, Lipton RB, Silberstein SD, et al. The migraine postdrome: An electronic diary study. Neurology. 2016; 87:309. doi: 10.1212/WNL.0000000000002789.

Cortel-LeBlanc MA, Orr SL, Dunn M, James D, Cortel-LeBlanc A. Managing and Preventing Migraine in the Emergency Department: A Review. Annals of emergency medicine. 2023;82(6):732-751. doi:10.1016/j.annemergmed.2023.05.024

Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology [published correction appears in Neurology 2000 Jan 9;56(1):142]. Neurology. 2000;55(6):754-762. doi:10.1212/wnl.55.6.754

Kent DL, Haynor DR, Longstreth WT Jr, Larson EB. The clinical efficacy of magnetic resonance imaging in neuroimaging. Annals of Internal Medicine. 1994;120(10):856-871. doi:10.7326/0003-4819-120-10-199405150-00007

Evans RW. Diagnostic testing for migraine and other primary headaches. Neurology Clinics. 2009;27(2):393-415. doi:10.1016/j.ncl.2008.11.009

Orr SL. Status Migrainosus: One of the Most Poorly Understood but Important Complications of Migraine. Neurology. 2023;100(3):107-108. doi:10.1212/WNL.0000000000201477

Schürks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ. 2009;339:b3914. doi:10.1136/bmj.b3914

Øie LR, Kurth T, Gulati S, Dodick DW. Migraine and risk of stroke. Journal of neurology, neurosurgery, and psychiatry. 2020;91(6):593-604. doi:10.1136/jnnp-2018-318254

Arboix A, Massons J, García-Eroles L, Oliveres M, Balcells M, Targa C. Migrainous cerebral infarction in the Sagrat Cor Hospital of Barcelona stroke registry. Cephalalgia. 2003;23(5):389-394. doi:10.1046/j.1468-2982.2003.00534.x

Mahmud R, Sina H. Presentation, Etiology, Outcome, and Differentiation of Visual Semiology of Adult Occipital Epilepsy From Visual Aura of Migraine Headache: A Prospective Study in a Tertiary Care Center in Bangladesh. Cureus. 2022;14(4):e24186. Published 2022 Apr 16. doi:10.7759/cureus.24186

Orr SL, Aubé M, Becker WJ, et al. Canadian headache society systematic review and recommendations on the treatment of migraine pain in emergency settings. Cephalalgia. 2014;0:1-14. doi: 10.1177/0333102414535997.

Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the American headache society evidence assessment of migraine pharmacotherapies. Headache. 2015;55:3-20. doi: 10.1111/head.12499.

Pringsheim T, Davenport J, Mackie G, et al. Canadian Headache Society Guideline for Migraine Prophylaxis: Supplement 2. Can J Neurological Sciences. 2012;39(S2):i-63. doi: https://doi.org/10.1017/S0317167100015109

Ailani J. Acute Migraine Treatment. Continuum. Minneap Minn; 2021. doi:10.1212/CON.0000000000000956

Al-Hashel JY, Abokalawa F, Toma R, et al. Worsening of migraine headache with fasting Ramadan. Clinical Neurolology and Neurosurgery. 2021;209: 106899. doi: 10.1016/j.clineuro.2021.106899.

Khorsha F, Mirzababaei A, Togha M, et al. Association of drinking water and migraine headache severity. Journal of Clinical Neuroscience. 2020;77:81-84. doi: 10.1016/j.jocn.2020.05.034.

Nurathirah MN, Yazid MB, Norhayati MN, et al. Efficacy of ketorolac in the treatment of acute migraine attack: a systematic review and meta-analysis. Academic Emergency Medicine. 2022;29:1118-1131. doi: 10.1111/acem.14457.

Orlova Y, Rizzoli P, Loder E. Association of coprescription of triptan antimigraine drugs and selective serotonin reuptake inhibitor or selective norepinephrine reuptake inhibitor antidepressants with serotonin syndrome. JAMA Neurology. 2018;75:566-572. doi: 10.1001/jamaneurol.2017.5144.

Worthington I, Pringsheim T, Gawel MJ, et al. Canadian Headache Society guideline: acute drug therapy for migraine headache. Canadian Journal of Neurological Sciences. 2013;40(S3):S1-S80. doi: https://doi.org/10.1017/S0317167100118943

Orr SL, Friedman BW, Christie S, et al. Management of adults with acute migraine in the emergency department: the American Headache Society evidence assessment of parenteral pharmacotherapies. Headache. 2016;56:911-940. doi: 10.1111/head.12835.

Regan LA, Hoffman RS, Nelson LS. Slower infusion of metoclopramide decreases the rate of akathisia. The American Journal of Emergency Medicine. 2009;27(4):475-480. doi: 10.1016/j.ajem.2008.03.044.

Vinson DR, Drotts DL. Diphenhydramine for the prevention of akathisia induced by prochlorperazine: a randomized, controlled trial. Annals of Emergency Medicine. 2001;37:125-131. doi: 10.1067/mem.2001.113032.

Parlak I, Erdur B, Parlak M, et al. Midazolam vs. Diphenhydramine for the treatment of metoclopramide-induced akathisia: a randomized controlled trial. Academic Emergency Medicine. 2007;14:715-721. doi: 10.1197/j.aem.2007.01.021.

Bigal ME, Bordini CA, Tepper SJ, et al. Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia. 2002;22:345-353. doi: 10.1046/j.1468-2982.2002.00364.x.

Wang F, Zhang H, Wang L, et al. Intravenous sodium valproate for acute migraine in the emergency department: a meta-analysis. Acta Neurologica Scandinavica. 2020;142:521-530. doi: 10.1111/ane.13325.

Viau JA, Patel D, Cheng W, et al. Sodium valproate versus dopamine antagonists for acute migraine in the emergency department: a systematic review. Canadian Journal of Neurological Sciences. 2022;49:688-695. doi: 10.1017/cjn.2021.195.

Patel D, Taljaard M, Yadav K, et al. Current practice for primary headache disorders and perspectives on peripheral nerve blocks among emergency physicians in Canada: a national survey. Headache. 2022;62:512-521. doi: 10.1111/head.14293.

Wolf SJ, Byyny R, Carpenter CR, et al. Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute headache. Annals of Emergency Medicine. 2019;74:e41-e74. doi: 10.1016/j.annemergmed.2019.07.009.

Lipton RB, Buse DC, Friedman BW, et al. Characterizing opioid use in a US population with migraine. Neurology. 2020;95(5):e457-e468. doi: 10.1212/WNL.0000000000009324.

Bigal ME, Lipton RB. Excessive opioid use and the development of chronic migraine. Pain. 2009;142:179-182. doi: 10.1016/j.pain.2009.01.013.

Robbins MS. Headache in pregnancy. Continuum. Minneap Minn; 2018. doi:10.1212/CON.0000000000000642

Lucas S, Rawner E. Approach to pregnant or lactating patients with headache in the emergency department. Orr S, Friedman B, Dodick D (eds). Emergency Headache. Cambridge University Press; 2017:125-140. doi: https://doi.org/10.1017/9781316819388.013

Gelecek

28 Şubat 2025

Lisans

Lisans